Advancements in AI-Driven Smart Nanocarriers for Controlled and Sustained Drug Release in Cancer Therapy

Abstract

Advanced cancer therapy has benefited significantly from the union of AI technology with nanotechnology by making possible intelligent nanocarriers that exist as effective platforms for sustained drug delivery. The artificial intelligence systems work by optimizing nanocarrier designs to provide selective drug delivery toward cancer sites without harming healthy tissue. AI algorithms optimize cancer therapy through personalization by evaluating unique patient data including genetic profiles alongside tumour elements in order to generate nanocarriers designed for specific requirements. Through AI control systems researchers can track drug release along with maintaining precise drug delivery concentrations during time-sensitive processes. The precise control of drug delivery through these systems increases therapeutic effects while reducing side effects thus resulting in superior patient results. The development of AI-driven smart nanocarriers presents a dramatic shift for cancer treatment while facing current obstacles of scale-up together with regulatory clearance but allows groundbreaking advancements in patient-specific treatments with increased effectiveness and lower toxicity levels during the future